GLENVIEW CAPITAL MANAGEMENT, LLC Portfolio

Auto-discovered 13F filer (Top-2000 by latest reported value).

SEC 13F CIK: 0001138995

What is a 13F filing? Who files one and when · What 13F filings can't tell you

MidFocusedHealth TiltHigh Turnover how tags are computed

Q2 2024 · 48 positions · Total reported value $5.08B · Top-10 concentration 62.6% · Updated 2026-10-18

Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR

Turnover: 69.6% · 13 new · 14 cut · 12 exited

Active Share (vs S&P 500): 87.0% · vs QQQ: 87.1% — share of the book that differs from index weights (higher = more active) · ranking

Est. Qtr Return (Q1 2026 → Q2 2026): +32.1% · vs SPY +17.3% · Prev Value $3.56B — last quarter positions weighted by this quarter price moves · ranking

In its Q2 2024 13F filing, GLENVIEW CAPITAL MANAGEMENT, LLC disclosed 48 equity positions with a combined reported value of $5.08B. The filing implies a focused portfolio: its ten largest positions account for 62.6% of reported value. HoldingsHub classifies the profile as Mid / Focused / Health Tilt / High Turnover.

The largest disclosed positions as of Q2 2024 were THC ($620.68M), CVS ($541.13M), CI ($427.69M). By sector, the heaviest allocations are Health Care 40.5%, Consumer Discretionary 20.6%. Versus the prior quarter, allocation shifted toward Consumer Staples (+6.8pp), Consumer Discretionary (+0.6pp) and away from Industrials (-1.0pp), Other (-2.9pp).

Versus the prior quarter, GLENVIEW CAPITAL MANAGEMENT, LLC opened 13 new positions, trimmed 14 and fully exited 12, a turnover rate of 69.6% of positions. The portfolio's overlap with the prior quarter was 72% of names.

The largest new positions opened in Q2 2024 were CNC ($94.90M), WCC ($60.52M), TFX ($25.76M).

Of the 12 positions fully exited versus the prior quarter, the largest were META ($53.07M), ARRY ($32.87M), AVGO ($26.54M).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q2 2024)

  • CNC CENTENE CORP DEL · $94.90M
  • WCC WESCO INTL INC · $60.52M
  • TFX TELEFLEX INCORPORATED · $25.76M
  • LYV LIVE NATION ENTERTAINMENT IN · $21.93M
  • GTM ZOOMINFO TECHNOLOGIES INC · $20.02M
  • CRS CARPENTER TECHNOLOGY CORP · $14.25M
  • LYFT LYFT INC · $11.51M
  • MTCH MATCH GROUP INC NEW · $10.76M

Fully Exited (vs previous quarter)

  • META META PLATFORMS INC CL-A · prev qtr: $53.07M · history
  • ARRY ARRAY TECHNOLOGIES INC · prev qtr: $32.87M
  • AVGO BROADCOM INC · prev qtr: $26.54M
  • W WAYFAIR INC · prev qtr: $14.91M
  • LBTYA LIBERTY GLOBAL LTD · prev qtr: $2.98M
  • CBUS CIBUS INC · prev qtr: $2.62M

Insider Transactions (Form 4)

Latest GLENVIEW CAPITAL MANAGEMENT, LLC buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.

Fund Profile

Glenview Capital Management is an SEC-registered 13F filer based in New York, NY, United States. As of Q2 2026 it reported 44 US equity positions with a combined value of $5.23B. HoldingsHub carries 12 quarters of its filings (Q3 2023–Q2 2026).

Firm Snapshot

  • Headquarters: NEW YORK, NY, United States
  • SEC registration: 801-73695 (status: Approved), registered 2012-03-30
  • Regulatory AUM (Form ADV): $6.37B as of 2026-09-15
  • Client mix (by RAUM): pension and profit-sharing plans 100%
  • Manages 6 private funds, of which 6 hedge funds

Portfolio Structure

  • 44 positions · $5.23B reported value (Q2 2026)
  • Top 10 holdings = 62.0% of reported value
  • Largest position: GPN (GLOBAL PMTS INC) at 12.4%
  • Average position size: $118.86M

Sector Tilt

  • Health Care 28.5%
  • Consumer Discretionary 26.6%
  • Industrials 14.0%
  • (classified holdings cover 91% of value)

Quarterly Activity

  • Q2 2026: 13 new, 14 added, 14 reduced, 12 exited
  • 3 positions unchanged

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

Sort by: Value Shares Weight Sector Change · CSV
# Shares Value Weight Allocation Change
1 4.67M $620.68M 12.22%
12.22%
Reduce
2 9.16M $541.13M 10.65%
10.65%
Add
3 1.29M $427.69M 8.42%
8.42%
Reduce
4 3.12M $301.54M 5.93%
5.93%
Add
5 5.07M $273.61M 5.38%
5.38%
Reduce
6 1.15M $233.75M 4.60%
4.60%
Hold
7 30.86M $227.72M 4.48%
4.48%
Add
8 1.18M $219.01M 4.31%
4.31%
Reduce
9 6.33M $171.59M 3.38%
3.38%
Reduce
10 8.71M $166.21M 3.27%
3.27%
Reduce
11 265.72K $155.19M 3.05%
3.05%
Reduce
12 9.16M $148.81M 2.93%
2.93%
Add
13 25.65M $145.96M 2.87%
2.87%
Add
14 2.49M $132.18M 2.60%
2.60%
Reduce
15 232.90K $126.75M 2.50%
2.50%
Reduce
16 1.43M $94.90M 1.87%
1.87%
New
17 3.75M $91.69M 1.80%
1.80%
Reduce
18 1.20M $87.01M 1.71%
1.71%
Add
19 599.44K $75.52M 1.49%
1.49%
Reduce
20 1.45M $72.62M 1.43%
1.43%
Add
21 6.49M $69.04M 1.36%
1.36%
Add
22 350.43K $67.72M 1.33%
1.33%
Reduce
23 195.59K $62.84M 1.24%
1.24%
Hold
24 381.77K $60.52M 1.19%
1.19%
New
25 862.67K $60.30M 1.19%
1.19%
Reduce
26 529.83K $55.38M 1.09%
1.09%
Add
27 98.58K $53.42M 1.05%
1.05%
Reduce
28 7.01M $47.86M 0.94%
0.94%
Reduce
29 3.61M $33.43M 0.66%
0.66%
Hold
30 425.63K $30.97M 0.61%
0.61%
Reduce
31 629.46K $26.59M 0.52%
0.52%
Add
32 122.48K $25.76M 0.51%
0.51%
New
33 233.90K $21.93M 0.43%
0.43%
New
34 484.01K $20.91M 0.41%
0.41%
Reduce
35 1.57M $20.02M 0.39%
0.39%
New
36 6.55M $16.70M 0.33%
0.33%
Add
37 1.11M $14.65M 0.29%
0.29%
Add
38 130.00K $14.25M 0.28%
0.28%
New
39 816.45K $11.51M 0.23%
0.23%
New
40 354.22K $10.76M 0.21%
0.21%
New
41 1.31M $9.11M 0.18%
0.18%
New
42 291.86K $9.05M 0.18%
0.18%
Hold
43 26.50M $8.86M 0.17%
0.17%
Add
44 53.77K $8.01M 0.16%
0.16%
Reduce
45 8.03M $6.75M 0.13%
0.13%
Hold
46 1.20M $792.52K 0.02%
0.02%
Reduce
47 15.99K $97.08K 0.00%
0.00%
Hold
48 1.71M $40.26K 0.00%
0.00%
Hold

FAQ

What did GLENVIEW CAPITAL MANAGEMENT, LLC buy in 2024-Q2?

In its 2024-Q2 13F filing, GLENVIEW CAPITAL MANAGEMENT, LLC reported 48 equity positions worth $5.08B in aggregate; its largest disclosed positions were THC ($620.68M), CVS ($541.13M), CI ($427.69M).

How large is GLENVIEW CAPITAL MANAGEMENT, LLC's portfolio?

GLENVIEW CAPITAL MANAGEMENT, LLC reported $5.08B of long equity holdings across 48 positions as of 2024-Q2. Top-10 holdings account for 62.6% of reported value.

What is GLENVIEW CAPITAL MANAGEMENT, LLC's investment style?

HoldingsHub classifies the portfolio as Mid / Focused / Health Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/glenview-capital-management/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →